Russell Index Exit Could Be A Game Changer For CareTrust REIT’s U.K. Strategy (CTRE)
CareTrust REIT, Inc. CTRE | 0.00 |
- In late June 2026, CareTrust REIT, Inc. (NYSE:CTRE) was removed from several Russell growth and small-cap indices, including the Russell 2000 Growth, Russell 2500 Growth, and Russell 3000 Growth benchmarks.
- This broad index removal can alter how index funds and other institutional investors hold or trade CareTrust shares, potentially affecting liquidity, investor base composition, and trading patterns.
- We will now examine how this broad removal from multiple Russell growth indices interacts with CareTrust REIT's acquisition-led, U.K.-focused investment narrative.
This technology could replace computers: discover 26 stocks that are working to make quantum computing a reality.
CareTrust REIT Investment Narrative Recap
To own CareTrust REIT, you need to believe in its acquisition driven expansion in U.S. skilled nursing and U.K. care homes, and in management’s ability to integrate new assets without eroding returns. The recent removal from several Russell growth and small cap indices may shift parts of the shareholder base and near term trading, but it does not appear to change the key catalyst of external growth or the main risks around integration and reimbursement exposure.
The most relevant recent announcement alongside the Russell changes is CareTrust’s June affirmation of its higher quarterly dividend of US$0.39 per share, following the March increase. For many REIT investors this income stream is a primary focus, and the dividend decision sits against the backdrop of rapid portfolio expansion, ongoing equity issuance, and the operational and regulatory risks tied to growing exposure in skilled nursing and the new U.K. platform.
Yet behind the reassuring dividend news, investors should be aware that integration risk across the enlarged, U.K. heavy portfolio could...
CareTrust REIT's narrative projects $970.3 million revenue and $494.9 million earnings by 2029. This implies 22.9% yearly revenue growth and an earnings increase of about $159.9 million from $335.0 million today.
Uncover how CareTrust REIT's forecasts yield a $45.50 fair value, a 11% upside to its current price.
Exploring Other Perspectives
Four fair value estimates from the Simply Wall St Community span roughly US$26 to US$102 per share, showing how far apart individual views can be. When you set that wide range against the current focus on integration risk in CareTrust’s fast expanding U.S. and U.K. portfolios, it underlines why it can pay to compare several different perspectives before forming an opinion.
Explore 4 other fair value estimates on CareTrust REIT - why the stock might be worth 36% less than the current price!
The Verdict Is Yours
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
- A great starting point for your CareTrust REIT research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.
- Our free CareTrust REIT research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate CareTrust REIT's overall financial health at a glance.
Ready To Venture Into Other Investment Styles?
Our top stock finds are flying under the radar-for now. Get in early:
- The future of work is here. Discover the 30 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
- Invest in the nuclear renaissance through our list of 89 elite nuclear energy infrastructure plays powering the global AI revolution.
- AI is about to change healthcare. These 40 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
